Generic Version of Feraheme Now Available
The first generic version of Feraheme (ferumoxytol injection) has been made available by Sandoz.
Diagnosis & Disease Information
Complications Develop in Half of COVID-19 Cases Treated in Hospitals
COVID-19 severity at hospital admission predicts complications even in young adults and those without pre-existing health conditions.
FDA Panel Votes on Roxadustat for Anemia in Chronic Kidney Disease
Concerns over thromboembolic events and MACE risk were discussed during the meeting.
Blood Shortages Causing Surgery Delays Across the United States
Some US blood centers have only a 1-day supply
Red Cross Warns of Severe Blood Shortage
Hospitals’ need for blood on the rise as they deal with many patients who delayed care due to the COVID-19 pandemic
More Bleeding Events After PCI in Women With Baseline Risk Factors
The researchers explored the association of sex with outcomes among patients treated with ticagrelor monotherapy vs ticagrelor plus aspirin.
SARS-CoV-2 RNAemia Infrequent in Blood Donors
Nucleic acid testing of donor plasma minipools (MPs) indicates that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNAemia is infrequent.
Blood Shortage Causes Surgery Delays in New England
While periodic, localized blood shortages are not uncommon, this shortage is ‘unprecedented in its scope’
10 Things Your Patients Should Know About Anemia
Though anemia is the most common blood disorder in the US, are patients educated on how it affects the body and how they have to manage it? Here is what they should know about anemia, how it is caused, and who is at risk.
Renoprotective Effect of SGLT2 Inhibitors Mediated Largely by Hematocrit
Increases in the proportion of red blood cells mediates the reduction in renal risks associated with SGLT2 inhibitor therapy in patients with type 2 diabetes and cardiovascular disease, a study found.
- Loading...
Loading...
Next post in Anemia
Loading... 
Loading...